These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31783510)

  • 21. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
    Hein TW; Wang W; Zoghi B; Muthuchamy M; Kuo L
    J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel trends in the treatment of cardiovascular disorders: site- and event- selective adenosinergic drugs.
    Szentmiklósi AJ; Cseppento A; Harmati G; Nánási PP
    Curr Med Chem; 2011; 18(8):1164-87. PubMed ID: 21291368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
    Hussain T; Linden J; Mustafa SJ
    J Pharmacol Exp Ther; 1996 Jan; 276(1):284-8. PubMed ID: 8558444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine receptors: new therapeutic targets for inflammation in diabetic nephropathy.
    Elsherbiny NM; Al-Gayyar MM
    Inflamm Allergy Drug Targets; 2013 Jun; 12(3):153-61. PubMed ID: 23621447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Adenosinergic System in Diabetic Retinopathy.
    Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF
    J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosinergic signaling as a target for natural killer cell immunotherapy.
    Wang J; Matosevic S
    J Mol Med (Berl); 2018 Sep; 96(9):903-913. PubMed ID: 30069747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine receptor ligands-recent developments part I. Agonists.
    Muller CE
    Curr Med Chem; 2000 Dec; 7(12):1269-88. PubMed ID: 11032971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular adenosine receptors; potential clinical applications.
    Ho MF; Rose'Meyer RB
    Curr Vasc Pharmacol; 2013 May; 11(3):327-37. PubMed ID: 22724462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of Adenosine Receptors: The State of the Art.
    Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
    Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-substituted adenosine receptor agonists. Synthesis and pharmacological activity as potent antinociceptive agents.
    Güngör T; Malabre P; Teulon JM; Camborde F; Meignen J; Hertz F; Virone-Oddos A; Caussade F; Cloarec A
    J Med Chem; 1994 Dec; 37(25):4307-16. PubMed ID: 7996542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases.
    Thiel M; Caldwell CC; Sitkovsky MV
    Microbes Infect; 2003 May; 5(6):515-26. PubMed ID: 12758281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases.
    Matsuoka I; Ohkubo S
    J Pharmacol Sci; 2004 Feb; 94(2):95-9. PubMed ID: 14978343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.
    Cohen FR; Lazareno S; Birdsall NJ
    Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling.
    Ciruela F; Albergaria C; Soriano A; Cuffí L; Carbonell L; Sánchez S; Gandía J; Fernández-Dueñas V
    Biochim Biophys Acta; 2010 Jan; 1798(1):9-20. PubMed ID: 19883624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.
    Geldenhuys WJ; Hanif A; Yun J; Nayeem MA
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28587166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The receptorial responsiveness method (RRM): a new possibility to estimate the concentration of pharmacologic agonists at their receptors].
    Pák K; Kiss Z; Erdei T; Képes Z; Gesztelyi R
    Acta Pharm Hung; 2014; 84(1):38-52. PubMed ID: 24809165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the adenosinergic system in a zebrafish embryo radiotherapy model.
    Cruz FF; Pereira TCB; Altenhofen S; da Costa KM; Bogo MR; Bonan CD; Morrone FB
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Oct; 224():108572. PubMed ID: 31306805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia.
    Riksen NP; Rongen GA; Blom HJ; Boers GH; Smits P
    Clin Chem Lab Med; 2005; 43(10):1001-6. PubMed ID: 16197288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cysteine residues of rat A2a adenosine receptors in agonist binding.
    Mazzoni MR; Giusti L; Rossi E; Taddei S; Lucacchini A
    Biochim Biophys Acta; 1997 Feb; 1324(1):159-70. PubMed ID: 9059509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.